Latest filing published 03 Nov 2022 for Clovis Oncology, Inc..
Thomas C. Harding is a declared insider of Clovis Oncology, Inc., with filings sourced from SEC (Form 4). Between 3 December 2020 and 1 November 2022, the trades on record add up to 56 filings.
Every open-market trade on record is a sale: 22 sales worth €107k. Outside the open market, there are 34 option exercises.
The record was last updated on 3 November 2022 with an option exercise in Clovis Oncology, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 56 declarations